ESC 365 - Influence of galectin-3 and soluble ST-2 on risk of death and heart failure hospitalization in patients after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention

HFA Premium Access

Influence of galectin-3 and soluble ST-2 on risk of death and heart failure hospitalization in patients after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention

Session: Poster Session 2 - Chronic Heart Failure – Diagnostic Methods

Topic: Biomarkers

Speaker: Doctor A. Tyminska (Warsaw, PL)

Event: Heart Failure 2019

Congress Presentation

Add to my library

About the speaker

Doctor Agata Tyminska

Medical University of Warsaw, Warsaw (Poland)

0 follower

20 more presentations in this session

The ratio of fibroblast growth factor 23 to phosphorus as a predictor of cardiovascular death in heart failure patients with reduced ejection fraction.

Speaker: Professor D. Gruson (Brussels, BE)

Soluble ST2/LVMI correlates with native T1 mapping value in 3T cardiac magnetic resonance in patients with dilated cardiomyopathy

Speaker: Associate Professor Y. Park (Yangsan, KR)

Dynamics of the stimulating growth factor sST2 and interleukin 33 in acute myocardial infarction

Speaker: Professor V. Larina (Moscow, RU)

BNP as the biomarker of diagnosis and prognosis in long-term mortality in a cohort with HFpEF and HFrEF in the south of Brazil

Speaker: Doctor E. Pitthan (Porto Alegre, BR)

Association between severity of heart failure and chemerin level

Access the full session

Poster Session 2 - Chronic Heart Failure – Diagnostic Methods

Speakers: Doctor A. Tyminska, Professor D. Gruson, Associate Professor Y. Park, Professor V. Larina, Doctor E. Pitthan

About the event

Heart Failure 2019

25 May - 28 May 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources